Who is the manufacturer of NIDO Baby Magnetic Resonance Imaging System?

Jiangsu Lici Medical Device Co., Ltd. filed the 510(k) submission for NIDO Baby Magnetic Resonance Imaging System (K242573).

What is the FDA product code for NIDO Baby Magnetic Resonance Imaging System?

LNH. It is classified under 21 CFR 892.1000 as a Class 2 device in the Radiology panel.

What is the regulatory pathway for NIDO Baby Magnetic Resonance Imaging System?

510(k) clearance (submission type: Traditional).

What are the predicate devices for NIDO Baby Magnetic Resonance Imaging System?

Embrace Neonatal MRI System (K170978); Lucy Point-of-Care Magnetic Resonance Imaging Device (K192002).

Who can help prepare an FDA 510(k) submission like NIDO Baby Magnetic Resonance Imaging System?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

NIDO Baby Magnetic Resonance Imaging System

K242573 · Jiangsu Lici Medical Device Co., Ltd. · LNH · Dec 23, 2024 · Radiology

Device Facts

Record ID	K242573
Device Name	NIDO Baby Magnetic Resonance Imaging System
Applicant	Jiangsu Lici Medical Device Co., Ltd.
Product Code	LNH · Radiology
Decision Date	Dec 23, 2024
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 892.1000
Device Class	Class 2
Attributes	Pediatric

Intended Use

The NIDO Baby Magnetic Resonance Imaging System is indicated for use as a magnetic resonance imaging device for producing axial, sagittal, coronal and oblique images that displays the internal structure of neonatal or infant head. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. The NIDO Baby Magnetic Resonance Imaging System is applicable to neonatal or infant head with circumference of up to 50 cm and weight up to 15Kg.

Device Story

NIDO Baby MRI System (model LCM-MRI-3500-01A) is an open-type 0.35T permanent magnet MRI system for neonatal/infant head imaging. Input: hydrogen atom magnetic resonance signals generated by body tissue in a magnetic field. Operation: system uses gradient system, RF system, and spectrometer to acquire 2D/3D images; integrated transceive RF head coil doubles as patient table. Output: MR images (Proton Density, T1, T2, Diffusion) displayed on a computer console. Used in medical facilities at point-of-care; operated by trained clinicians. Output interpreted by physicians to assist in diagnosis. Benefits: non-invasive imaging without ionizing radiation, specifically sized for neonates/infants.

Clinical Evidence

Bench testing only. No clinical data presented. Verification and validation included software testing (IEC 62304), image performance (NEMA MS-1, MS-2, MS-3, MS-5, MS-12), biocompatibility (ISO 10993), electrical safety/EMC (IEC 60601 series), and SAR characterization (NEMA MS-8).

Technological Characteristics

0.35T permanent magnet; open U-shaped structure. Gradient strength ≤32 mT/m; slew rate ≤107 T/m/s. Resonance frequency 14.6-14.9 MHz. Integrated transceive RF head coil. Software supports Spin Echo, Fast Spin Echo, FLASH, FLAIR, and DWI pulse sequences. Biocompatibility per ISO 10993. Electrical safety per IEC 60601-1; EMC per IEC 60601-1-2.

Indications for Use

Indicated for neonatal or infant head imaging (circumference up to 50 cm, weight up to 15 kg) to produce axial, sagittal, coronal, and oblique images for diagnostic use by a trained physician.

Regulatory Classification

Identification

A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).

Special Controls

*Classification.* Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Predicate Devices

Embrace Neonatal MRI System (K170978)
Lucy Point-of-Care Magnetic Resonance Imaging Device (K192002)

Related Devices

K170978 — Embrace Neonatal MRI System · Aspect Imaging, Ltd. · Jul 19, 2017
K254277 — Embrace Neonatal MRI System · Aspect Imaging, Ltd. · Mar 13, 2026
K091047 — NEONATE ARRAY COILS · Lmt Medical Systems GmbH · Aug 18, 2010
K023929 — MAGNETIC RESONANCE DIAGNOSTIC DEVICE · Advanced Imaging Research, Inc. · Feb 21, 2003
K253499 — Ascent3T Neonatal Magnetic Resonance Imaging System · Eyas Medical Imaging, Inc. · Jan 26, 2026

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. December 23, 2024 Jiangsu LiCi Medical Device Co., Ltd. % Rachel Yu Manager Zhihe Info-Tech (Suzhou) Co., Ltd. Room 616, Building 1, No. 1 Huayun Road, Industrial Park. Suzhou City Jiangsu, Suzhou 215134 China Re: K242573 Trade/Device Name: NIDO Baby Magnetic Resonance Imaging System Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic Resonance Diagnostic Device Regulatory Class: Class II Product Code: LNH Dated: October 31, 2024 Received: October 31, 2024 Dear Rachel Yu: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Page 2 Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory {2}------------------------------------------------ assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Daniel M. Krainak, Ph.D. Assistant Director DHT8C: Division of Radiological Imaging and Radiation Therapy Devices OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ # Indications for Use Submission Number (if known) K242573 Device Name NIDO Baby Magnetic Resonance Imaging System ### Indications for Use (Describe) The NIDO Baby Magnetic Resonance Imaging System is indicated for use as a magnetic resonance imaging device for producing axial, sagittal, coronal and oblique images that displays the internal structure of neonatal or infant head. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. The NIDO Baby Magnetic Resonance Imaging System is applicable to neonatal or infant head with circumference of up to 50 cm and weight up to 15Kg. Type of Use (Select one or both, as applicable) Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) # CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ## *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {4}------------------------------------------------ # 510(k) summary ### I. Submitter | Device Submitter: | Jiangsu LiCi Medical Device Co., Ltd. | |-------------------|------------------------------------------| | | 277 Yuzhou South Road, Haizhou District, | | | Lianyungang, Jiangsu, China | | Contact Person: | Bing Keong Li | |-----------------|-------------------------------| | | Title: General Manager | | | E-mail: joeli@licimedical.com | | Date Prepared: | August 29, 2024 | ## II Device Trade Name of Device: NIDO Baby Magnetic Resonance Imaging System Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic Resonance Diagnostic Device Common Name: Magnetic Resonance Imaging System Regulatory Class: Class II Product code: LNH Review Panel: Radiology # III Predicate Device 1 | Trade Name: | Embrace Neonatal MRI System | |-------------------------|--------------------------------------| | Regulation Number: | 21 CFR 892.1000 | | Regulation Name: | Magnetic Resonance Diagnostic Device | | Regulatory Class: | Class II | | Product Code: | LNH | | Premarket Notification: | K170978 | | Manufacturer: | Aspect Imaging Ltd. | # IV Predicate Device 2 | Trade Name: | Lucy Point-of-Care Magnetic Resonance Imaging Device | |-------------------------|------------------------------------------------------| | Regulation Number: | 21 CFR 892.1000 | | Regulation Name: | Magnetic resonance diagnostic device | | Regulatory Class: | Class II | | Product Code: | LNH | | Premarket Notification: | K192002 | | Manufacturer: | Hyperfine Research, Inc. | {5}------------------------------------------------ #### V Device Description The NIDO Baby Magnetic Resonance Imaging System, model LCM-MRI-3500-01A, is a specialized open-type MRI system designed for neonatal and infant head imaging. The system utilized a 0.35 Tesla (T) permanent magnet to acquire 2D single-slice, multi-slice, and 3D volume images of the brain. Magnetic Resonance Imaging (MRI) is a non-invasive medical imaging technique that uses strong magnetic fields, radio waves, and a computer to produce detailed images of the internal structures of the body. Unlike X-rays or CT scans, MRI does not use ionizing radiation. Instead, it relies on the magnetic properties of atoms in the body, particularly hydrogen atoms, which are abundant in water and fat. When a patient is placed inside the MRI machine, the powerful magnets that create a strong magnetic field around the patient causes hydrogen atoms in the body to align with the field. Once the hydrogen atoms are aligned, radio waves are sent into the body. These waves temporarily disrupt the alignment of the hydrogen atoms. When the radio waves are turned off, the hydrogen atoms return to their original alignment, emitting signals in the process. These signals are detected by the MRI machine and converted into detailed images of the body's internal structures. The NIDO Baby Magnetic Resonance Imaging System features a 0.35T permanent magnet with an open U-shaped structure, optimized for MR head imaging of neonatal and infant patients. Key components include the magnet system, gradient system, radio frequency (RF) system, spectrometer system, temperature control system and clinical imaging software. The system's gradient field strength is ≤32 mT/m with a slew rate of ≤107 T/m/s. Integrated transceive RF head coil also functions as a patient table, operating within a resonance frequency range of 14.6 MHz to 14.9 MHz is used to acquired MR images and to provide patient safety and comfort during scanning. The high-performance computer console is installed with clinical imaging software, which includes a variety of pulse sequences, such as Spin Echo, Fast Spin Echo, Fast Low Angle Shot Gradient Echo, Fluid-Attenuated Inversion Recovery and Diffusion-Weighted Imaging for Proton Density, T1 weighted, T2 weighted and Diffusion imaging. #### VI Indications for Use The NIDO Baby Magnetic Resonance Imaging System is indicated for use as a magnetic resonance imaging device for producing axial, sagittal, coronal and oblique images that displays the internal structure of neonatal or infant head. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. The NIDO Baby Magnetic Resonance Imaging System is applicable to neonatal or infant head with circumference {6}------------------------------------------------ of up to 50 cm and weight up to 15Kg. # VII Substantial Equivalence Discussion | Items | Subject Device NIDO Baby Magnetic Resonance Imaging System | Predicate Device 1 Embrace Neonatal MRI System (K170978) | Predicate Device 2 Lucy Point-of-Care Magnetic Resonance Imaging Device (K192002) | | |---------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------| | Indications for Use | The NIDO Baby Magnetic Resonance Imaging System is indicated for use as a magnetic resonance imaging device for producing axial, sagittal, coronal and oblique images that displays the internal structure of neonatal or infant head. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. The NIDO Baby Magnetic Resonance Imaging System is applicable to neonatal or infant head with circumference of up to 50 cm and weight up to 15Kg. | The Embrace Neonatal MRI System is indicated for use as a magnetic resonance imaging device for producing axial, sagittal, coronal and oblique images that displays the internal structure of neonatal head with a circumference of up to 38 cm and weight between 1Kg and 4.5 Kg. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. | The Lucy Point-of-Care Magnetic Resonance Imaging Device is a bedside magnetic resonance imaging device for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. | | | Product Code | LNH | LNH | LNH | | | Regulation Number | 21 CFR 892.1000 | 21 CFR 892.1000 | 21 CFR 892.1000 | | | Class | CLASS II | CLASS II | CLASS II | | | Environment of Use | At the point of care in medical facilities including emergency | Hospital setting | At the point of care in medical facilities including emergency rooms, critical | | | Items | Subject Device NIDO Baby Magnetic Resonance Imaging System | Predicate Device 1 Embrace Neonatal MRI System (K170978) | Predicate Device 2 Lucy Point-of-Care Magnetic Resonance Imaging Device (K192002) | | | Anatomical sites | rooms, critical care units, hospital. | care units, hospital or rehabilitation rooms. | | | | | Neonatal or infant head | Neonatal Head | Head | | | Energy Used and/or Delivered | Magnetic Resonance | Magnetic Resonance | Magnetic Resonance | | | Patient Population | Neonatal or infant head with circumference of up to 50 cm and weight up to 15Kg. | Neonates with head circumference of up to 38 cm and weight between 1Kg and 4.5 Kg | Adult and pediatric patients (above 2 years old) | | | Human Factors | The product is designed similar to other commercially available MRI systems and therefore is familiar and easy for use for the user. Furthermore, the device contains a user-friendly software interface through which the user may easily access all device functions. | The Embrace Neonatal MRI System is designed similar to other commercially available MRI Systems and therefore is familiar and easy for use for the user. Furthermore, the device contains a user-friendly software interface through which the user may easily access all device functions. | Lucy is designed similar to other commercially available MRI Systems and therefore is familiar and easy to use for the user. Furthermore, the device contains a user-friendly software interface through which the user may easily access all device functions. | | | Magnet | Physical Dimensions | 109cm x 83cm x 138.5cm | 171cm x 145cm x 220cm | 835 mm x 630 mm x 652 mm | | | Bore Opening | 260mm Wide | 184x260mm | 610 mm x 315 mm | | | Weight | 4500Kg | 5500(5680 with PB) Kg | 320 kg | | | Field Strength | 0.35Tesla Permanent Magnet | 1.0Tesla Permanent Magnet | 64 mT permanent magnet | | Gradient | Strength | 32mT/m | 150mT/m | 16 mT/m | | | Rise Time | 0.3mSec | 0.3mSec | 0.5 ms | | | Slew Rate | 107T/m/Sec | 500T/m/Sec | 28 T/m/s | | Computer Display | | 27" LED Display | 24" LED Display | User supplied tablet | | RF Coils | | 1 head coil | 1 head coil | 1 head coil | | Coil Type | | TX/RX | TX/RX | RX | | Items | Subject Device NIDO Baby Magnetic Resonance Imaging System | Predicate Device 1 Embrace Neonatal MRI System (K170978) | Predicate Device 2 Lucy Point-of-Care Magnetic Resonance Imaging Device (K192002) | | | Coil Geometry | Oval | Cylindrical | Form-fitting | | | Coil Design | Linear Volume | Linear Volume | Linear Volume | | | Patient Table Dimensions | 139.5cm x 24.5cm x 91.8cm | 140cm x 60.6cm x 120cm | N/A | | | Patient Weight Capacity | 15kgs Max | 4.5kgs Max | 200 kg | | | Electrical Safety | Evaluated according to IEC 60601-1 | Evaluated according to IEC 60601-1 | Evaluated according to IEC 60601-1 | | | EMC | Evaluated according to IEC 60601-1-2 | Evaluated according to IEC 60601-1-2 | Evaluated according to IEC 60601-1-2 | | | Max SAR for | Evaluated according to | Evaluated according to | Evaluated according to IEC | | | Transmit Coil | IEC 60601-2-33, | IEC 60601-2-33, | 60601-2-33, | | | Max dB/dt | Comply with IEC 60601-2-33 | Comply with IEC 60601-2-33 | Comply with IEC 60601-2-33 | | | Biocompatibility | Patient contact materials were tested and demonstrated no cytotoxicity (ISO 10993-5), no evidence for (ISO 10993-10). | Patient contact materials were tested and demonstrated no cytotoxicity (ISO 10993-5), no evidence for irritation and sensitization (ISO 10993-10). | Patient contact materials were tested and demonstrated no cytotoxicity (ISO 10993-5), no evidence for irritation and sensitization (ISO 10993-10). | | Table VII-1 Substantial equivalence discussion {7}------------------------------------------------ {8}------------------------------------------------ The NIDO Baby Magnetic Resonance Imaging System have the same intended use, technology, design and performance specifications are either identical or substantially equivalent to existing legally marketed predicate devices. The differences between the NIDO Baby Magnetic Resonance Imaging System and predicate devices do not alter suitability of the proposed device for its intended use. #### VIII Non-Clinical Tests As part of demonstrating substantial equivalence to the predicate, a risk-based assessment was completed to identify the risks associated with the modifications. Based on the risk assessment, the following verification and validation testing was performed. The subject device passed all the testing in accordance with internal requirements and applicable standards to support substantial equivalence. {9}------------------------------------------------ | Test | Test Description | Applicable Standard(s) | |--------------------------|-----------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------| | Software Verification | Software verification testing in accordance with the design requirements to ensure that the software requirements were met. | IEC 62304:2015 FDA Guidance, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices | | Image Performance | Testing to verify the subject device meets all image quality criteria. | NEMA MS-1-2008(R2020) NEMA MS-2-2008(R2020) NEMA MS-3-2008(R2020) NEMA MS-5-2018 NEMA MS-12-2016 | | Software Validation | Validation to ensure the subject device meets user needs and performs as intended. | FDA Guidance, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices | The following testing was leveraged from the predicate device. Test results from the predicate were used to support the subject device because the conditions were identical or the subject device modifications did not introduce a new worst-case configuration or scenario for testing. | Test | Test Description | Applicable Standard(s) | |------------------|-----------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------| | Biocompatibility | Biocompatibility testing of patient-contacting materials. | ISO 10993-1:2018 ISO 10993-5:2009 ISO 10993-10:2021 ISO 10993-23:2021 | | Safety | Electrical Safety, EMC, and Essential Performance testing. | IEC 60601-1: 2020 IEC 60601-1-2:2020 IEC 60601-1-6:2020 IEC 60601-2-33:2022 NEMA MS-4-2010 | | Performance | Characterization of the Specific Absorption Rate or Magnetic Resonance Imaging Systems. | NEMA MS-8-2016 | | Cybersecurity | Testing to verify cybersecurity controls and management. | Cybersecurity as recommended in FDA guidance, "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices | {10}------------------------------------------------ # IX Conclusion Based on the intended use, technological characteristics, performance results, and comparison to the predicate, the subject NIDO Baby Magnetic Resonance Imaging System has been shown to be substantially equivalent to the predicate device identified in this submission and does not present any new issues of safety or effectiveness.